Rich Riley: I was going to say we were active. We’ve retained a large leading executive search firm. We’ve got an exciting pipeline of candidates and so we’re very much in the process. Don’t yet have a start date planned. But we’ve got Nate with us through September 01, and he’s got an advisory role through the end of the year. So we’re confident that we will have a smooth transition.
Operator: The next question comes from Eric Stine – Craig-Hallum. Please go ahead.
Eric Stine: Hi, everyone. Maybe I’ll just start with the order book. I know $10 billion plus. As you just said, most of that’s para-xylene and I know those customers are committed to the long term, but this means with this change of the timeline that they’re waiting quite a bit. are there any mechanisms within that that if it’s a customer that would have a need for FDCA? What’s the — how does that work? Or, is there the potential that you hand off some of this order book to a potential licensee? Or, just trying to think about that dynamic from the customer’s point of view.
Rich Riley: Sure. Well, Eric, we’re excited to cross the $10 billion milestone and a lot of the recent growth was from FDCA, which has been a large focus of ours in recent quarters and many of our para-xylene customers do also have an interest and, in many cases, a capacity reservation with us for FDCA. So, there certainly are synergies in those two materials for many of our customers. But we do have a large order book for para-xylene and PET and we are very committed to delivering against that order book and are optimistic that we’ll be able to deliver those materials in the timeframe that those customers want and largely in partnership with other companies. And if you think about, we talked about SEGP recently. We’ve talked about our Indorama relationship.
There are multiple partners that we’re working with that have the potential to help us deliver bio-para-xylene at large scale in a relevant timeline for those customers and those customers very much want those materials, there really aren’t any other ways of getting them and so, we are very optimistic that they’ll continue to work with us to deliver those materials.
Eric Stine: Got it. And then, just as we think about the change of the timeline, I can appreciate higher, obviously, higher interest rates, but, that’s a new dynamic since this all got started and you first gave that number for Origin 2 back in 2021, but it’s not new here over the last number of quarters. So, I’m just trying to kind of think about, how much of this can be ascribed to that, a higher rate environment versus, as you said, it’s FDCA. You just need, more time needed on the development side.
Rich Riley: Yeah, so really, I think the first thing that’s worth thinking about is and keeping in mind is how long it takes to turn a new engineering investment. And so, as we have made adjustments and thought about sort of how to put both the opportunities that have been presented and the challenges that have arisen into a sort of bucket and then figure out what’s the best way to navigate through those sorts of things. Generally speaking, it can be very difficult to understand what the impact of those is going to be on something like a final cost or revenue number, or even a schedule, frankly, until you turn that through tens of thousands of hours of engineering time to convert that into a new scenario, right? And in our case, we were actually running multiple scenarios and put them in.
